PolyPeptide Group AG (SWX:PPGN)
39.55
+0.80 (2.06%)
Jun 23, 2026, 5:31 PM CET
PolyPeptide Group AG Revenue
In the year 2025, PolyPeptide Group AG had annual revenue of 389.33M EUR with 15.60% growth. PolyPeptide Group AG had revenue of 222.23M in the half year ending December 31, 2025, with 17.87% growth.
Revenue
389.33M EUR
Revenue Growth
+15.60%
P/S Ratio
3.60
Revenue / Employee
270.37K EUR
Employees
1,440
Market Cap
1.31B CHF
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 389.33M | 52.54M | 15.60% |
| Dec 31, 2024 | 336.79M | 16.42M | 5.13% |
| Dec 31, 2023 | 320.37M | 39.39M | 14.02% |
| Dec 31, 2022 | 280.98M | -1.15M | -0.41% |
| Dec 31, 2021 | 282.13M | 57.83M | 25.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 45.38B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| Aevis Victoria | 1.04B |
| Tecan Group AG | 882.48M |
| SKAN Group AG | 333.34M |
| Medartis Holding AG | 269.26M |
PolyPeptide Group AG News
- 7 days ago - PolyPeptide price target raised to CHF 38 from CHF 35 at Berenberg - TheFly
- 7 days ago - PolyPeptide price target raised to CHF 40 from CHF 33 at Barclays - TheFly
- 2 months ago - PolyPeptide is attracting takeover interest from EQT, KKR, Bloomberg says - TheFly
- 3 months ago - PolyPeptide Group AG Earnings Call Transcript: H2 2025 - Transcripts
- 3 months ago - PolyPeptide Group AG Earnings release: H2 2025 - Filings
- 3 months ago - PolyPeptide Group AG Annual report: H2 2025 - Filings
- 3 months ago - PolyPeptide Group AG Slides: H2 2025 - Filings
- 6 months ago - PolyPeptide price target lowered to CHF 33 from CHF 35 at Barclays - TheFly